What’s the State of AI-enabled Automation in Pharma R&D?
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
Pharma
Novel Drugs: The Case for Applied Behavioural Science in Driving Take up
Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Here, Alpharmaxim’s William Hind…
Getting RIM Contracting Right to Secure a Data-first Future
Effective vendor selection and contracting is critical to support regulatory information management capabilities that increasingly lie at the heart of quality and clinical processes. Romuald…
Modern by (Trial) Design: Shedding Legacy EDC Systems to Gain Clinical Capacity
As trials become increasingly complex, companies share how leaving behind legacy EDC systems can save thousands of hours during study build and testing. In today’s…
Digital Tools can Help Patients and Healthcare Providers Navigate the Rapidly Changing Oncology Treatment Landscape
The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD and this number is…
Revolutionising Drug Development: Key Takeaways from the ICON Biotech Survey
In the dynamic landscape of biotechnology, ICON’s recent survey of over 100 leaders from the biotech industry dissects the challenges and opportunities faced by biotech…
2024 – Tech & Biotech Outlook
We’re in a new era of biotech, defined by the interplay between biology, data and AI. And it’s the enabling technologies — the connected instruments,…
Generative AI and its Impact on Speed to Market for Pharmaceuticals
Did you know that it takes approximately seven years to develop and bring a new drug to market? However, this time can be significantly reduced…
Signal Detection Innovation Boosts Safety and Uncovers Commercial Opportunities
Smart analytics applied to real-world data are increasingly enabling companies to track adverse effects, while at the same time identifying opportunities for drug repurposing. ArisGlobal’s…
A Look Back: The Life Sciences Industry in 2023, and a View for 2024
The breakneck pace of digital transformation spurred by COVID-19 continued to reshape the life sciences landscape in 2023. Rather than a single watershed moment, this…